Critique of trials in allergic bronchopulmonary aspergillosis and fungal allergy

References

• Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis. A review and a report of eight new cases. Thorax 1952; 7: 317–333
   PubMed Web of Science ®Google Scholar
• Mearns M, Young W, Batten J. Transient pulmonary infiltrations in cystic fibrosis due to allergic aspergillosis. Thorax 1965; 20: 385–392
   Web of Science ®Google Scholar
• Rosenberg M, Rosenberg M, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405–414
   PubMed Web of Science ®Google Scholar
• Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685–692
   PubMed Web of Science ®Google Scholar
• Wang JL, Patterson R, Roberts M, et al. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979; 120: 87–92
   PubMed Web of Science ®Google Scholar
• Capewell S, Chapman BJ, Alexander F, et al. Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax 1989; 44: 925–929
   PubMed Web of Science ®Google Scholar
• Patterson R, Greenberger PA, Radin RD, et al. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 1982; 96: 286–291
   PubMed Web of Science ®Google Scholar
• Patterson R, Greenberger PA, Halwig JM, et al. Allergic bronchopulmonary aspergillosis: Natural history and classification of disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146: 916–918
   PubMedGoogle Scholar
• Mussaffi H, Rivlin J, Shalit I, et al. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005; 25: 324–328
   PubMed Web of Science ®Google Scholar
• Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis – State of the Art. Clin Infect Dis 2003; 37: S225–264
   Web of Science ®Google Scholar
• Schubert MS, Goetz DW. Evaluation and treatment of allergic fungal sinusitis – II. Treatment and follow-up. J Allergy Clin Immunol 1998; 102: 395–402
   PubMed Web of Science ®Google Scholar
• Hilton AM, Chatterjee SS. Bronchopulmonary aspergillosis – treatment with beclomethasone dipropionate. Postgrad Med J 1975; 51(Suppl 4)98–103
   PubMedGoogle Scholar
• Heinig JH, Weeke ER, Groth S, et al. High-dose local steroid treatment in bronchopulmonary aspergillosis. A pilot study. Allergy 1988; 43: 24–31
   PubMed Web of Science ®Google Scholar
• Balter MS, Rebuck AS. Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids. Respir Med 1992; 86: 441–442
   PubMed Web of Science ®Google Scholar
• Imbeault B, Cormier Y. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis. Chest 1993; 103: 1614–1617
   PubMed Web of Science ®Google Scholar
• Seaton A, Seaton RA, Wightman AJ. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up. QJM 1994; 87: 529–537
   PubMed Web of Science ®Google Scholar
• Report to the Research Committee of the British Thoracic Association. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Br J Dis Chest 1979; 73: 349–356
   PubMedGoogle Scholar
• Hubner M, Hochhaus G, Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Immunol All Clin N Am 2005; 25: 469–488
   PubMed Web of Science ®Google Scholar
• Parmar JS, Howell T, Kelly J, et al. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 2002; 57: 749–750
   PubMed Web of Science ®Google Scholar
• Main KM, Skov M, Sillesen IB, et al. Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. Acta Paediatr 2002; 91: 1008–1011
   PubMed Web of Science ®Google Scholar
• Skov M, Main KM, Sillesen IB, et al. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 2002; 20: 127–133
   PubMed Web of Science ®Google Scholar
• De Wachter E, Vanbesien J, De Schutter I, et al. Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide. Eur J Pediatr 2003; 162: 488–489
   PubMed Web of Science ®Google Scholar
• De Wachter E, Malfroot A, De Schutter I, et al. Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2003; 2: 72–75
   PubMedGoogle Scholar
• Bolland MJ, Bagg W, Thomas MG, et al. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole. Ann Pharmacother 2004; 38: 46–49
   PubMed Web of Science ®Google Scholar
• Mannes GP, van der Heide S, van Aalderen WM, et al. Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis. Lancet 1993; 341: 492
   PubMed Web of Science ®Google Scholar
• Pacheco A, Martin JA, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 1993; 103: 980–981
   PubMed Web of Science ®Google Scholar
• Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 1995; 107: 883
   PubMed Web of Science ®Google Scholar
• Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999; 116: 1665–1668
   PubMed Web of Science ®Google Scholar
• Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756–762
   PubMed Web of Science ®Google Scholar
• Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952–957
   PubMed Web of Science ®Google Scholar
• Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2004; CD001108.
   PubMedGoogle Scholar
• Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 2004; 98: 915–923
   PubMed Web of Science ®Google Scholar
• Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Role of atopy and response to itraconazole. Chest 1999; 115: 364–370
   PubMed Web of Science ®Google Scholar
• Skowronski E, Fitzgerald DA. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis. Med J Aust 2005; 182: 482–483
   PubMed Web of Science ®Google Scholar
• Denning DW, Van Wye JE, Lewiston NJ, et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100: 813–819
   PubMed Web of Science ®Google Scholar
• Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 2002; 57: 723–728
   PubMed Web of Science ®Google Scholar
• Casaulta C, Fluckiger S, Crameri R, et al. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol 2005; 16: 217–225
   PubMed Web of Science ®Google Scholar
• Elphick H, Southern K. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev 2000; CD002204.
   PubMedGoogle Scholar
• Casey P, Garrett J, Eaton T. Allergic bronchopulmonary aspergillosis in a lung transplant patient successfully treated with nebulized amphotericin. J Heart Lung Transplant 2002; 21: 1237–1241
   PubMed Web of Science ®Google Scholar
• Hilliard T, Edwards S, Buchdahl R, et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005; 4: 215–220
   PubMedGoogle Scholar
• Thomson JM, Wesley A, Byrnes CA, et al. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol 2006; 41: 164–170
   PubMed Web of Science ®Google Scholar
• Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987; 42: 26–31
   PubMed Web of Science ®Google Scholar
• Currie DC, Lueck C, Milburn HJ, et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax 1990; 45: 447–450
   PubMed Web of Science ®Google Scholar